← Eichor
Condition: Nervous System Tumor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nervous System Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
NA · 1 location(s) · West China Hospital · NCT07316101
Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy
Phase 1 · 1 location(s) · University Hospital of Split · NCT06595329
PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07717281
rTMS for Postoperative Brain Tumor Patients
NA · 1 location(s) · Brian J.Gill · NCT07530536
AnovaOS Network Powered Patient Registry
Phase N/A · 1 location(s) · Anova Enterprises, Inc · NCT05013944
Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases
NA · 10 location(s) · Susanne Rogers · NCT05124236
Implementation of CBT-I in Cancer Clinics
NA · 1 location(s) · CHU de Quebec-Universite Laval · NCT04817163
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
Phase 2 · 1 location(s) · Kevin Kim, MD · NCT07237100
Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatm
NA · 11 location(s) · Centre Oscar Lambret · NCT06211257
Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibi
Phase N/A · 6 location(s) · Shantou University Medical College · NCT07357636
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924
Creation of a Clinical Database on Primary Nervous System Tumors
Phase N/A · 1 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04516720
Postop Pain Management in Pituitary Tumour Patients
Phase 4 · 1 location(s) · Hamilton Health Sciences Corporation · NCT06353529
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Phase N/A · 23 location(s) · Alexion Pharmaceuticals, Inc. · NCT06967480
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
Phase 2 · 1 location(s) · TYK Medicines, Inc · NCT05948813
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Phase 2 · 18 location(s) · VA Office of Research and Development · NCT04038502
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Phase 1 · 1 location(s) · Baptist Health South Florida · NCT06048094
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
Phase N/A · 12 location(s) · AstraZeneca · NCT06909253
Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
NA · 1 location(s) · Korea University Guro Hospital · NCT07102446
The "Let's Talk Tech" Tool to Support Decision Making About Technology Use
NA · 1 location(s) · University of Washington · NCT06817122
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
EARLY_Phase 1 · 12 location(s) · C17 Council · NCT06942039
Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer
Phase N/A · 1 location(s) · Hanneke W. M. van Laarhoven · NCT06519292
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05419076
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Phase 1/Phase 2 · 2 location(s) · Case Comprehensive Cancer Center · NCT01891318
Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)
Phase N/A · 1 location(s) · The First Affiliated Hospital of Zhengzhou University · NCT06930586
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease P
Phase 2 · 2 location(s) · Elixiron Immunotherapeutics Inc. · NCT06745583
Neurocognition After Radiotherapy in CNS- and Skull-base Tumors
NA · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05727605
Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults
NA · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04501705
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.